Early recurrence of nephrotic syndrome (immunoglobulin m nephropathy) after renal transplantation successfully treated with combinations of plasma exchanges, immunoglobulin, and rituximab.
暂无分享，去创建一个
S. Hansson | L. Mjörnstedt | J. Mölne | S. Friman | S. Swerkersson | S. Westphal | Styrbjörn Friman | Sverker Hansson | Johan Mölne
[1] B. Tönshoff,et al. Recurrence of Focal-Segmental Glomerulosclerosis in Children after Renal Transplantation: Clinical and Genetic Aspects , 2005, Transplantation.
[2] M. Fujisawa,et al. Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome , 2005, Pediatric Nephrology.
[3] P. Mathieson,et al. Recurrence of IgM nephropathy in a renal allograft. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[4] J. Dötsch,et al. Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy , 2004, Pediatric Nephrology.
[5] Heikki Helin,et al. IgM nephropathy: clinical picture and long-term prognosis. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[6] S. Shariatmadar,et al. Therapeutic plasma exchange in recurrent focal segmental glomerulosclerosis following transplantation , 2002, Journal of clinical apheresis.
[7] L. Solomon,et al. Reduction of post-transplant proteinuria due to recurrent mesangial proliferative (IgM) glomerulonephritis following plasma exchange. , 1981, Clinical Nephrology.